🇺🇸 FDA
Patent

US 7714009

Nitrogen-containing fused heterocyclic compounds

granted A61PA61P25/00A61P25/22

Quick answer

US patent 7714009 (Nitrogen-containing fused heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P25/00, A61P25/22, A61P25/24, A61P43/00